Inhibitory Activity of Bevacizumab to Differentiation of Retinoblastoma Cells
Authors:
Open Access
- 22 March 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (3) , e33456
Abstract
Vascular endothelial growth factor (VEGF) is a major regulator in retinal and choroidal angiogenesis, which are common causes of blindness in all age groups. Recently anti-VEGF treatment using anti-VEGF antibody has revolutionarily improved the visual outcome in patients with vaso-proliferative retinopathies. Herein, we demonstrated that bevacizumab as an anti-VEGF antibody could inhibit differentiation of retinoblastoma cells without affection to cellular viability, which would be mediated via blockade of extracellular signal-regulated kinase (ERK) 1/2 activation. The retinoblastoma cells expressed VEGFR-2 as well as TrkA which is a neurotrophin receptor associated with differentiation of retinoblastoma cells. TrkA in retinoblastoma cells was activated with VEGF treatment. Interestingly even in the concentration of no cellular death, bevascizumab significantly attenuated the neurite formation of differentiated retinoblastoma cells, which was accompanied by inhibition of neurofilament and shank2 expression. Furthermore, bevacizumab inhibited differentiation of retinoblastoma cells by blockade of ERK 1/2 activation. Therefore, based on that the differentiated retinoblastoma cells are mostly photoreceptors, our results suggest that anti-VEGF therapies would affect to the maintenance or function of photoreceptors in mature retina.Keywords
This publication has 32 references indexed in Scilit:
- Fine-Tuning Roles of Endogenous Brain-Derived Neurotrophic Factor, TrkB and Sortilin in Colorectal Cancer Cell SurvivalPLOS ONE, 2011
- THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN OCULAR HEALTH AND DISEASERetina, 2005
- Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factorJournal of Neuroscience Research, 2004
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- The biology of VEGF and its receptorsNature Medicine, 2003
- Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivoProceedings of the National Academy of Sciences, 2002
- Coordinated Interaction of Neurogenesis and Angiogenesis in the Adult Songbird BrainNeuron, 2002
- Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disordersSeminars in Cell & Developmental Biology, 2002
- RetinoblastomaArchives of Ophthalmology (1950), 1995
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989